Displaying items by tag: harbert institute for innovation and entrepreneurship

The Zorro-Flow Inc. is the newest startup from the UAB Harbert Institute for Innovation and Entrepreneurship. The device is the first external catheter to collect urine effectively, safely and comfortably from critically ill female neonates and children.
Thaddaeus Kwan, Ph.D., became one the first Innovate fellows in the Harbert Institute for Innovation and Entrepreneurship while a postdoc at UAB. He now works in HIIE as a project analyst — and heads the Fellows program.
All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival.
Researchers have been awarded a $2.6 million, four-year National Institutes of Health grant to evaluate a safer and more durable stent design, using techniques licensed through the UAB Harbert Institute for Innovation and Entrepreneurship by the UAB spinoff company Endomimetics LLC.
The monoclonal antibody cocktail is deliverable via a nasal dose, and it is also effective against SARS, MERS and several coronavirus cold viruses. The antibodies are engineered for long-acting effectiveness, potentially lasting a year or more when used in humans.
In advance of public vaccination, a quick and accurate COVID-19 antibody test will help determine the presence of neutralizing antibodies, the molecules that aid in protection against the virus.
A local early-stage startup has been approved for low-cost, low-risk, non-invasive procedures for patients with chronic liver disease.
The research is led by an Oregon cancer research institute, in collaboration with two biotech companies and the National Institutes of Health.